Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Women of all ages will get round-the-clock access to comprehensive treatment
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories
Experts’ conclave to pave holistic approach to cancer management
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
Acquisitions have the potential to add at least $1 billion in sales by 2028
Subscribe To Our Newsletter & Stay Updated
